Pre-validation of TMPRSS2:ERG+PCA3 risk models for men on active surveillance

Utility of models incorporating urine biomarkers, T2:ERG and PCA3 in prostate cancer
439

No coordinating investigator defined.

ERG, PSA, TMPRSS2
No design specified.
UNKNOWN
Prostate and Urologic Cancers Research Group

No datasets are currently associated with this protocol.


Version 5.1.0